Patient burden and quality of life in atopic dermatitis in US adults-Reference-Cited by-同舟云学术

Patient burden and quality of life in atopic dermatitis in US adults

Published:2018-09 Issue:3 Volume:121 Page:340-347
ISSN:1081-1206
Container-title:Annals of Allergy, Asthma & Immunology
language:en
Short-container-title:Annals of Allergy, Asthma & Immunology

Author:

Silverberg Jonathan I.,Gelfand Joel M.,Margolis David J.,Boguniewicz Mark,Fonacier Luz,Grayson Mitchell H.^ORCID,Simpson Eric L.,Ong Peck Y.^ORCID,Chiesa Fuxench Zelma C.

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine,Immunology and Allergy,Immunology

Reference36 articles.

1. Burden of skin pain in atopic dermatitis;Vakharia;Ann Allergy Asthma Immunol,2017

2. Patient burden of moderate to severe atopic dermatitis (AD): Insights from a phase 2b clinical trial of dupilumab in adults;Simpson;J Am Acad Dermatol,2016

3. Increasing comorbidities suggest that atopic dermatitis is a systemic disorder;Brunner;J Invest Dermatol,2017

4. New developments in comorbidities of atopic dermatitis;Silverberg;Cutis,2014

5. Association between severe eczema in children and multiple comorbid conditions and increased healthcare utilization;Silverberg;Pediatr Allergy Immunol,2013

Cited by 427 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Patient Burden of Atopic Dermatitis and Opportunities for Real-World Self-Monitoring;Dermatologic Clinics;2024-10

2. Algorithms in allergy: Diagnosis and management of atopic dermatitis in adulthood;Allergy;2024-09-11

3. Consensus on a Patient-Centered Definition of Atopic Dermatitis Flare;JAMA Dermatology;2024-09-11

4. Improvement Across Dimensions of Disease with Lebrikizumab Use in Atopic Dermatitis: Two Phase 3, Randomized, Double-Blind, Placebo-Controlled Monotherapy Trials (ADvocate1 and ADvocate2);Advances in Therapy;2024-09-09

5. Lebrikizumab Combined with Topical Corticosteroids Improves Patient-reported Outcomes in Japanese Patients with Moderate-to-severe Atopic Dermatitis;Acta Dermato-Venereologica;2024-09-09